Abstract
In general, the management and reported outcomes for elderly patients with squamous
cell carcinoma of the head and neck (SCCHN) have been similar to those of younger
patients. But older adults are a distinct subpopulation of patients who differ from
younger patients due to their increased risks for: comorbidities, decreased functional
status, a potential decline in cognitive function and an increase in vulnerabilities.
Older adults have been underrepresented in the clinical trials which define our best
treatment strategies. This review explores the evidence used to establish common practice
in managing SCCHN and evaluates the relevance of this evidence for the older adult,
concluding with recommendations based on the review.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Geriatric OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Global cancer statistics.CA Cancer J Clin. 2011; 61: 69-90
- Chapter 2: cancers of the head and neck in cancer survival among adults: U.S. SEER Program, 1988–2001.in: Reis L. Young J. Keel G. Eisner M. Lin Y. Hormer M. SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988–2001. Patient and Tumor Characteristics. National Cancer Institute, 2007 (SEER Program, NIH Pub. No. 07-6215, Bethesda, Maryland)
- A practical approach to Geriatric assessment in oncology.J Clin Oncol. 2007; 25: 1936-1944
- How does older age influence an oncologists' cancer management.Oncologist. 2010; 15: 1584-1592
- Importance of functional measures in predicting mortality among older hospitalized patients.JAMA. 1998; 279: 1187-1193
- Development and validation of a prognostic index for 4 year mortality in older adults.JAMA. 2006; 295: 801-808
- Cancer screening in elderly patients.JAMA. 2001; 285: 2750-2756
- Comprehensive geriatric assessment for older patients with cancer.J Clin Oncol. 2007; 25: 1824-1831
- The vulnerable elders survey: a tool for identifying vulnerable older people in the community.J Am Geriatr Soc. 2001; 49: 1691-1699
- Detecting disabilities in older patients with cancer; comparison between comprehensive geriatric assessment and Vulnerable Elders Survey — 13.J Clin Oncol. 2010; 28: 2046-2050
- Validation of a screening tool for elderly patients in oncology. ASCO Annual Meeting Abstracts.J Clin Oncol. 2008; 26 (May 20 suppl.; abstr 19670)
- Can the vulnerable elders survey — 13 and/or the G8 adequately identify elderly patients with head and neck cancer in need of comprehensive geriatric assessment?.J Clin Oncol. 2011; 29 (suppl.; abstre 19670.)
- Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery.Surg Oncol. 2006; 15: 189-197
- Shall we operate? Preoperative assessment in elderly cancer patients. (PACE) can help: an SIOG surgical task force prospective study.Crit Rev Oncol Hematol. 2008; 65: 156-163
- Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.J Clin Oncol. 2011; 29: 3457-3465
- The chemotherapy risk assessment scale for high-age patients (CRASH) score: design and validation. ASCO meeting abstracts.J Clin Oncol. 2010; 28 (abstr 9000)
- Surgical outcomes for patients aged 80 and older: morbidity and mortality from major noncardiac surgery.J Am Geriatr Soc. 2005; 53: 424-429
- Age as a prognostic factor for complications of major head and neck surgery.Arch Otolaryngol Head Neck Surg. 2005; 131: 605-609
- Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery.Head Neck. 2008; 30: 170-177
- Microvascular free tissue transfer in elderly patients: the Toronto experience.Head Neck. 2003; 25: 549-553
- Age as a prognostic factor for head and neck squamous cell carcinoma: should older patients be treated differently?.J Otolaryngol. 2006; 35: 8-12
- Should older head and neck patients be treated differently?.Eur Ann Otorhinolaryngol Head Neck Dis. 2011; 128: 165-168
- Head and neck cancer surgery in the elderly — does age influence the postoperative course?.Oral Oncol. 2010; 46: 92-95
- Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases.Arch Otolaryngol Head Neck Surg. 2001; 127: 1089-1092
- Quality of life in elderly patients with head and neck cancer one year after diagnosis.Head Neck. 2004; 26: 1045-1052
- Cancer-directed surgery for localized disease: decreased use in the elderly.Ann Surg Oncol. 2004; 11: 962-969
- No age limit for radical radiotherapy in head and neck tumors.Eur J Cancer. 1996; 32A: 2075-2081
- Radiotherapy in head and neck cancer in the elderly: a challenge.Crit Rev Oncol Hematol. 2000; 34: 195-203
- Head and neck cancer in the elderly: an overview of treatment modalities.Cancer Treat Rev. 2009; 35: 237-245
- Patterns of care in elderly head and neck cancer radiation oncology patients: a single cohort study.Int J Radiat Biol Phys. 2011; 79: 46-51
- Meta analysis of radiotherapy in carcinoma of the head and neck.Curr Opin Oncol. 2007; 19: 188-194
- Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy.J Clin Oncol. 2008; 26: 5119-5125
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.MACH-NC Collaborative Group. 2009; 92: 4-14
- Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.J Clin Oncol. 2008; 26: 3582-3589
- Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.N Eng J Med. 2003; 349: 2091-2098
- Preliminary results of Radiation Therapy Oncology Group 97–03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinoma of the head and neck.J Clin Oncol. 2004; 22: 2856-2864
- EGFR antagonists in cancer treatment.N Eng J Med. 2008; 358: 1160-1174
- Open label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.J Clin Oncol. 2007; 25: 2171-2177
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomized trial, and relation between cetuximab induced rash and survival.Lancet Oncol. 2010; 11: 21-28
- Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer.N Engl J Med. 2007; 357: 1695-1704
- Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.N Engl J Med. 2007; 357: 1705-1715
- Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.N Engl J Med. 2004; 350: 1945-1952
- Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.N Engl J Med. 2004; 350: 1937-1944
- Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501).Head Neck. 2005; 27: 843-850
- Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.J Clin Oncol. 2004; 22: 262-268
- Platinum based chemotherapy plus cetuximab in head and neck cancer.N Eng J Med. 2008; 359: 1116-1127
- Head and neck squamous cell carcinoma in patients aged ≥ 80.Cancer. 2008; 113: 3160-3168
- A matched survival analysis for squamous cell carcinoma of the head and neck in the elderly.Laryngoscope. 2003; 113: 368-372
- Head and neck squamous cell carcinoma in elderly patients.Arch Otolaryngol Head Neck Surg. 2001; 127: 1089-1092
- Population based study of competing mortality in head and neck cancer.J Clin Oncol. 2011; 29: 3503-3509
- Treatment of head and neck cancer in the elderly.Eur Arch Otorhinolaryngol. 2010; 267: 1619-1621
- The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods.Ann Intern Med. 2010; 153: 194-199
Article info
Publication history
Published online: March 23, 2012
Accepted:
February 22,
2012
Received in revised form:
February 14,
2012
Received:
October 28,
2011
Identification
Copyright
Published by Elsevier Inc.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Erratum to “Management of squamous cell carcinoma of the head and neck in the elderly: Review and recommendations” [J. Geriatr. Oncol. 3 (2012) 265–272]Journal of Geriatric OncologyVol. 4Issue 1
